World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
55
Citations
13013
World Ranking
14900
National Ranking
1175

Overview

Bernd R. Seizinger is affiliated with Oxford Biotherapeutics, located in the United Kingdom. Their work is situated within the biotherapeutics sector, contributing to this scientific and medical field through their professional engagements.

While detailed information about their specific research papers, co-authors, publication venues, or fields of study is not available, their association with an organization focused on biotherapeutics suggests expertise related to the development of therapeutic agents and biological treatments.

There is no publicly available record of awards or honors associated with Bernd R. Seizinger. Similarly, details on co-authors or collaborations have not been documented in the accessible data.

The absence of published research articles, frequent publication venues, or listed research topics limits the ability to provide a comprehensive overview of scientific contributions. However, their current affiliation indicates an active role in the biotechnology and therapeutic innovation sector within the United Kingdom.

Best Publications

  • A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor

    James A. Trofatter;Mia M. MacCollin;Joni L. Rutter;Jill R. Murrell

  • Induction of the growth inhibitor IGF-binding protein 3 by p53

    Leonard Buckbinder;Randy Talbott;Susana Velasco-Miguel;Ivone Takenaka

  • Von Hippel–Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma

    B. R. Seizinger;G. A. Rouleau;L. J. Ozelius;A. H. Lane

  • Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma.

    Bernd R. Seizinger;Robert L. Martuza;James F. Gusella

  • Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan.

    Berton Zbar;Takeshi Kishida;Fan Chen;Laura Schmidt

  • Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22

    G A Rouleau;W Wertelecki;J L Haines;W J Hobbs

  • Subsets of Glioblastoma Multiforme Defined by Molecular Genetic Analysis

    Andreas von Deimling;Klaus von Ammon;David Schoenfeld;Otmar D. Wiestler

  • Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene

    B.R. Seizinger;G.A. Rouleau;L.J. Ozelius;A.H. Lane

  • High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas

    Albert B. Bianchi;Shin-Ichiro Mitsunaga;Jin Quan Cheng;Walter M. Klein

  • Molecular genetic approach to human meningioma: loss of genes on chromosome 22

    B R Seizinger;S de la Monte;L Atkins;J F Gusella

  • p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma.

    Andreas von Deimling;Robert H. Eibl;Hiroko Ohgaki;David N. Louis

  • Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis

    BR Seizinger;G Rouleau;LJ Ozelius;AH Lane

  • Evidence for a Tumor Suppressor Gene on Chromosome 19q Associated with Human Astrocytomas, Oligodendrogliomas, and Mixed Gliomas

    von Deimling A;Louis Dn;Louis Dn;von Ammon K;Petersen I

  • Regulation of the Sequence-specific DNA Binding Function of p53 by Protein Kinase C and Protein Phosphatases

    Ivone Takenaka;Francine Morin;Bernd R. Seizinger;Nikolai Kley

  • Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types.

    Bianchi Ab;Hara T;Ramesh;Gao J

  • PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes

    Susana Velasco-Miguel;Leonard Buckbinder;Leonard Buckbinder;Patrice Jean;Patrice Jean;Larry Gelbert

  • Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme.

    Andreas von Deimling;David N. Louis;Klaus von Ammon;Iver Petersen

  • Comparative study of p53 gene and protein alterations in human astrocytic tumors.

    David N. Louis;Andreas von Deimling;Richard Y. Chung;Mari Paz Rubio

  • Exon scanning for mutation of the NF2 gene in schwannomas

    Jacoby Lb;MacCollin M;Louis Dn;Mohney T

  • Specific Genetic Change in Tumors Associated With von Hippel-Lindau Disease

    Kalman Tory;Hiltrud Brauch;Marston Linehan;David Barba

Frequent Co-Authors

James F. Gusella
James F. Gusella Harvard University
Robert L. Martuza
Robert L. Martuza Harvard Medical School
David N. Louis
David N. Louis Harvard University
Guy A. Rouleau
Guy A. Rouleau Montreal Neurological Institute and Hospital
Andreas von Deimling
Andreas von Deimling Heidelberg University
Avery A. Sandberg
Avery A. Sandberg Roswell Park Cancer Institute
Otmar D. Wiestler
Otmar D. Wiestler German Cancer Research Center
Bertrand Fontaine
Bertrand Fontaine Université Paris Cité
David W. Yandell
David W. Yandell Harvard University
Bruce A.J. Ponder
Bruce A.J. Ponder University of Cambridge

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Advancing your education in Biology and Biochemistry can open doors to diverse and impactful careers in healthcare and research. For those interested in administration, exploring the top online mha programs that are cahme accredited can prepare you for leadership roles in hospitals, clinics, or public health organizations.

If you are a nursing professional aiming for a terminal degree, dnp online no clinicals programs offer flexibility—enabling you to study at your own pace without on-site clinical requirements.

Interested in a broader management perspective? Consider pursuing a management-focused doctorate, such as those listed among the best doctorate of healthcare administration programs. These degrees can help you transition into high-level executive positions in healthcare systems.

Lastly, if your passion lies in pharmaceuticals and patient care, you might explore an online pharmacy school to launch or advance your career as a pharmacist. Each of these pathways complements core biology and biochemistry studies, preparing you for specialized, in-demand roles in today’s healthcare landscape.

Best Scientists Citing Bernd R. Seizinger

Recently Published Articles